Granules India
GRANULESNSE

Granules India

₹633.1512.75 (2.06%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events
Livesquawk
Granules India's Shamirpet facility cleared by US FDA after inspection. US FDA clearance granted to Granules Life Sciences for compliance.
Livesquawk
Granules: US FDA inspection led to voluntary action classification. Post-inspection closure, FDA took no further regulatory action.
Livesquawk
Granules India's US subsidiary received a favorable FDA report with no action needed. The facility is vital for OTC product packaging and distribution.